Haoxi Health Technology Limited (HAO) is an Advertising company listed on NASDAQ. There were no new wire items for HAO in the last 30 days. The most recent was published Sep 30, 2026.
Financial highlights
Full financials- Revenue, FY2026
- $54.83M
- Revenue growth
- +67.1%
- Net income, FY2026
- -$9.54M
- Net margin
- -17.4%
- Cash
- $10.93M
For fiscal 2026 (ended Jun 30, 2026), from SEC filings. Not investment advice.
News · 26 weeks17-100%
2026-05-102026-11-01
Mix290d
- Other2(100%)
Latest news
25 items- SECSEC Form 20-F filed by Haoxi Health Technology Limited20-F - Haoxi Health Technology Ltd (0001954594) (Filer)
- PRHaoxi Health Technology Limited Announces 1-For-20 Reverse Share SplitBEIJING, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (NASDAQ:HAO, ", we", or the ", Company", )), today announced that it will effect a reverse share split of its outstanding Class A ordinary shares, par value $0.0000001 per share (the "Class A Ordinary Shares") and Class B ordinary shares, par value $0.0000001 per share (the "Class B Ordinary Shares"), at a ratio of 1-for-20. Our Class A Ordinary Shares will begin trading on a reverse share split-adjusted basis at the opening of The Nasdaq Capital Market ("Nasdaq") on August 14, 2026. Following the reverse share split, the Class A Ordinary Shares and Class B Ordinary Shares will have a new par value of $0.000002 per
- PRHaoxi Health Technology Limited Announces Strategic Cooperation Framework with NOVA MEDIA to Develop An AI Digital Marketing SystemBEIJING, July 14, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the "Company" or "HAO"), a Beijing-headquartered online marketing solutions provider specializing in one-stop digital marketing services for the health and wellness industry, today announced the signing of a strategic cooperation framework agreement with NOVA MEDIA, a technology company with expertise in AI digital humans and generative AI. Under the agreement, NOVA MEDIA will develop an AI digital marketing system (the "System") for HAO that is designed to support content production through AI-enabled tools and standardized workflows. The System will integrate AI digital human technology, automated content gener
- PRUnivest Securities, LLC Announces Closing of $4 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)New York, July 13, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the "Offering") of approximately $4 million for its client Haoxi Health Technology Ltd (NASDAQ:HAO) (the "Company"), a Beijing-headquartered online marketing solution provider in China, specializing in serving healthcare industry advertiser clients. Under the terms of the securities purchase agreement, the Company has agreed to sell to certain investors an aggregate of approximately $4 million of the Company's securities, including 10,
- SECSEC Form 6-K filed by Haoxi Health Technology Limited6-K - Haoxi Health Technology Ltd (0001954594) (Filer)
- SECSEC Form 424B5 filed by Haoxi Health Technology Limited424B5 - Haoxi Health Technology Ltd (0001954594) (Filer)
- PRHaoxi Health Technology Ltd Announces $4 Million Registered Direct OfferingBEIJING, July 10, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Ltd (NASDAQ:HAO) ("Haoxi" or the "Company"), today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of 10,000,000 of the Company’s Class A Ordinary Shares, par value $0.32 per share (the "Shares") (or pre-funded warrants in lieu thereof) at a purchase price of $0.40 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.33 per share. The aggregate gross proceeds to the Company of this offering are expected to be approximately $4 million. Th
- SECSEC Form 6-K filed by Haoxi Health Technology Limited6-K - Haoxi Health Technology Ltd (0001954594) (Filer)
- SECSEC Form 6-K filed by Haoxi Health Technology Limited6-K - Haoxi Health Technology Ltd (0001954594) (Filer)
- SECSEC Form 6-K filed by Haoxi Health Technology Limited6-K - Haoxi Health Technology Ltd (0001954594) (Filer)
- SECSEC Form 6-K filed by Haoxi Health Technology Limited6-K - Haoxi Health Technology Ltd (0001954594) (Filer)
- INSIDERCEO & Chairman Fan Zhen bought $720,000 worth of Class B Ordinary Shares (40,000,000 units at $0.02), increasing direct ownership by 5,790% to 40,690,800 units (SEC Form 4)4 - Haoxi Health Technology Ltd (0001954594) (Issuer)
- SECSEC Form 6-K filed by Haoxi Health Technology Limited6-K - Haoxi Health Technology Ltd (0001954594) (Filer)
- PRHaoxi Health Technology Limited Announces 1-For-128 Reverse Share SplitBEIJING, May 19, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (NASDAQ:HAO, "we" or the "Company")), today announced that it will effect a reverse share split of its outstanding Class A ordinary shares, par value $0.0025 per share (the "Class A Ordinary Shares") and Class B ordinary shares, par value $0.0025 per share (the "Class B Ordinary Shares"), at a ratio of 1-for-128. Our Class A Ordinary Shares will begin trading on a reverse share split-adjusted basis at the opening of The Nasdaq Capital Market ("Nasdaq") on May 21, 2026. Following the reverse share split, the Class A Ordinary Shares and Class B Ordinary Shares will have a new par value of $0.32 per share and the Class
- PRUnivest Securities, LLC Announces Closing of $6.5 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)New York, May 12, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the "Offering") of $6.5 million for its client Haoxi Health Technology Ltd (NASDAQ:HAO)(the "Company"), a Beijing-headquartered technology company engaged in the provision of online marketing solutions for healthcare industry clients, with a focus on short-form video and news feed advertising across major Chinese digital platforms. Under the terms of the securities purchase agreement, the Company has agreed to sell to certain investors
- SECSEC Form 424B5 filed by Haoxi Health Technology Limited424B5 - Haoxi Health Technology Ltd (0001954594) (Filer)
- PRHaoxi Health Technology Ltd Announces $6.5 Million Registered Direct OfferingBEIJING, May 11, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Ltd (NASDAQ:HAO) ("Haoxi" or the "Company") today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of approximately $6.5 million of the Company's securities, including 9,000,000 Class A ordinary shares, par value $0.0025 per share (the "Shares") and 16,999,998 pre-funded warrants, at a purchase price of $0.25 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.0026 per share. Each pre-funded warrant is exercisable to purchase 10.355 Shares
- SECSEC Form 6-K filed by Haoxi Health Technology Limited6-K - Haoxi Health Technology Ltd (0001954594) (Filer)
- SECSEC Form 6-K filed by Haoxi Health Technology Limited6-K - Haoxi Health Technology Ltd (0001954594) (Filer)
- INSIDERSEC Form 3 filed by new insider Xu Lei Lx3 - Haoxi Health Technology Ltd (0001954594) (Issuer)
- INSIDERSEC Form 3 filed by new insider Su Changmao3 - Haoxi Health Technology Ltd (0001954594) (Issuer)
- INSIDERSEC Form 3 filed by new insider Fan Zhen3 - Haoxi Health Technology Ltd (0001954594) (Issuer)
- INSIDERSEC Form 3 filed by new insider Li Dongxue3 - Haoxi Health Technology Ltd (0001954594) (Issuer)
- INSIDERSEC Form 3 filed by new insider Hu Chuanjie3 - Haoxi Health Technology Ltd (0001954594) (Issuer)
- INSIDERSEC Form 3 filed by new insider Liu Jia3 - Haoxi Health Technology Ltd (0001954594) (Issuer)
HAO FAQ
9 questionsWhat is the latest news on HAO?
Quantisnow has not tracked any new filings, ratings or press releases for HAO in the last 30 days. The most recent wire item was published on September 30, 2026.What is HAO revenue?
Haoxi Health Technology Limited (HAO) reported $54.83M of revenue for fiscal 2026 (ended Jun 30, 2026). That is up 67.1% from the year before.Is HAO profitable?
No. Haoxi Health Technology Limited reported a net loss of $9.54M for fiscal 2026 (ended Jun 30, 2026).How much cash and debt does HAO have?
Haoxi Health Technology Limited reported $10.93M in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does HAO stock trade?
Haoxi Health Technology Limited (HAO) is listed on NASDAQ.What sector and industry is HAO in?
Haoxi Health Technology Limited operates in the Consumer Discretionary sector, Advertising industry.When did Haoxi Health Technology Limited go public?
Haoxi Health Technology Limited (HAO) completed its IPO in 2024.What companies are similar to HAO?
Notable peers in the same industry include OMC (Omnicom Group Inc.), WPP (WPP plc), STGW (Stagwell Inc.), IBTA (Ibotta Inc.), MNTN (MNTN Inc.). Compare HAO side-by-side with any of them on Quantisnow.How can I track HAO on Quantisnow?
Quantisnow aggregates Haoxi Health Technology Limited's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HAO to receive live email and push alerts on every new disclosure.